Xiaochuan Yang Filiz Sen Mark B Geyer
10.1016/j.lrr.2019.100186
Leuk Res Rep
2019 Nov 26;12:100186.
acute lymphoblastic leukemia immunotherapy inotuzumab ozogamicin older adults
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/31867204/
Case Reports
PMC6904788
31867204
Inotuzumab ozogamicin as chemotherapy-sparing salvage in a 67-year-old man with primary refractory B-cell acute lymphoblastic leukemia with high-risk genomic features
2019